Jeffrey H. Cooper : Appointed to Board of ProNAi Therapeutics
Alumnus Jeffrey H. Cooper MBA ‘80 has been appointed to the Board of Directors for ProNAi Therapeutics.
"Mr. Cooper [has] extensive and relevant experiences in guiding the financial functions of public healthcare companies. [He] brings a commitment to the important role of sound financial management in governing an emerging public company," said Donald Parfet, Chairman of the Board of Directors of ProNAi, in a recent press release.
ProNAi Therapeutics, Inc. is a clinical-stage oncology company advancing novel therapeutics for patients with cancer and hematological diseases.
Find the full press release here.